Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124133953 | 12413395 | 3 | F | 20120912 | 20160922 | 20160527 | 20160927 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33968BI | BOEHRINGER INGELHEIM | 81.49 | YR | M | Y | 101.60000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124133953 | 12413395 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | N | 22512 | 150 | MG | CAPSULE | BID | |||||
| 124133953 | 12413395 | 2 | C | PACERONE | AMIODARONE HYDROCHLORIDE | 1 | Unknown | 200 MG | 0 | TABLET | |||||||||
| 124133953 | 12413395 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MEQ | 0 | 81 | MEQ | TABLET | QD | ||||||
| 124133953 | 12413395 | 4 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0.4 MG | 0 | .2 | MG | TABLET | BID | ||||||
| 124133953 | 12413395 | 5 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 975 MEQ | 0 | 325 | MEQ | TABLET | TID | ||||||
| 124133953 | 12413395 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 124133953 | 12413395 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG | 0 | 100 | MG | CAPSULE | Q12H | ||||||
| 124133953 | 12413395 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG | 0 | 20 | MG | TABLET | BID | ||||||
| 124133953 | 12413395 | 9 | C | HYDRALAZINE HCL | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 75 MG | 0 | 25 | MG | TABLET | TID | ||||||
| 124133953 | 12413395 | 10 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 30 MG | 0 | 5 | MG | TABLET | Q4H | ||||||
| 124133953 | 12413395 | 11 | C | METAPROLOL TARTRATE | METOPROLOL TARTRATE | 1 | Oral | 100 MG | 0 | 50 | MG | TABLET | Q12H | ||||||
| 124133953 | 12413395 | 12 | C | PRAVASTATIN NA | PRAVASTATIN SODIUM | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 124133953 | 12413395 | 13 | C | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLET | ||||||||
| 124133953 | 12413395 | 14 | C | TAMSULOSIN HCL | TAMSULOSIN | 1 | Oral | 0.4 MG | 0 | .4 | MG | CAPSULE | QD | ||||||
| 124133953 | 12413395 | 15 | C | ANDROGEL | TESTOSTERONE | 1 | Topical | 1% 2.5 GM PKT | 0 | GEL | QD | ||||||||
| 124133953 | 12413395 | 16 | C | TIOTROPIUM | TIOTROPIUM | 1 | Respiratory (inhalation) | 18MCG INHL CAP 30 INHALE 1 CAPSULE VIA ACTIVE INHALER BY MOUTH EVERY DAY (USE WTH INHALER, DO NOT SW | 0 | ||||||||||
| 124133953 | 12413395 | 17 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | Oral | 200 MG | 0 | 50 | MG | TABLET | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124133953 | 12413395 | 1 | Atrial fibrillation |
| 124133953 | 12413395 | 2 | Product used for unknown indication |
| 124133953 | 12413395 | 3 | Product used for unknown indication |
| 124133953 | 12413395 | 4 | Blood pressure measurement |
| 124133953 | 12413395 | 5 | Product used for unknown indication |
| 124133953 | 12413395 | 6 | Product used for unknown indication |
| 124133953 | 12413395 | 7 | Product used for unknown indication |
| 124133953 | 12413395 | 8 | Blood pressure measurement |
| 124133953 | 12413395 | 9 | Blood pressure measurement |
| 124133953 | 12413395 | 10 | Pain |
| 124133953 | 12413395 | 11 | Product used for unknown indication |
| 124133953 | 12413395 | 12 | Blood cholesterol decreased |
| 124133953 | 12413395 | 13 | Product used for unknown indication |
| 124133953 | 12413395 | 14 | Product used for unknown indication |
| 124133953 | 12413395 | 15 | Product used for unknown indication |
| 124133953 | 12413395 | 16 | Product used for unknown indication |
| 124133953 | 12413395 | 17 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124133953 | 12413395 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124133953 | 12413395 | Internal haemorrhage | |
| 124133953 | 12413395 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124133953 | 12413395 | 1 | 20120612 | 20130816 | 0 |